Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Lucid Group Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Lucid Group Inc trades at $3.3 (market cap $1.32B). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 3× Lucid Group Inc's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Lucid Group Inc for 45 Days on average.
| EWTX | LCID | |
|---|---|---|
Market Cap | $3.94B | $1.32B |
Volume | 810,104 | 8,737,624 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $21.67 |
52-Week Low | $14.89 | $3.29 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $3.48B | $4.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lucid Group (LCID) trades at $3.29, down 4.22% on the day, reflecting persistent investor concerns over its financial health. The stock shows a bearish technical signal with all moving averages indicating sell signals, while oscillators like the RSI suggest potential oversold conditions. Fundamentally, the company reported a net loss of $2.70 billion on $1.35 billion revenue in 2025, with negative margins and cash burn. Recent news highlights strategic partnerships for autonomous vehicles but also delays in key product launches and cost-saving initiatives critical for turnaround.
The outlook remains highly speculative with significant execution risks. While analyst consensus price target of $7.00 implies upside, the majority hold ratings and ongoing losses pose substantial downside. Investment opportunity hinges on successful cost reduction and new model execution, but bankruptcy risks and cash burn necessitate caution for equity holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
